Cleared Traditional

K091262 - MR CARDIAC FUNCTION ANALYSIS

K091262 is the FDA 510(k) clearance for MR CARDIAC FUNCTION ANALYSIS by Ziosoft, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 61-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2009
Decision
61d
Days
Class 2
Risk

K091262 is an FDA 510(k) clearance for the MR CARDIAC FUNCTION ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ziosoft, Inc. (Redwood City, US). The FDA issued a Cleared decision on June 29, 2009 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ziosoft, Inc. devices

Submission Details

510(k) Number K091262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 2009
Decision Date June 29, 2009
Days to Decision 61 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 107d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K091262.
INNOVA VISION, MODEL S18751VN, INNOVA TRACKVISION, MODEL S18751VT, INNOVA EPVISION, MODEL S18751EP
K092639 · GE Medical Systems SCS · Dec 2009
INTEGRATED REGISTRATION
K093234 · GE Medical Systems SCS · Oct 2009
CORONIS 5MP HD, MODEL MDMG 5121
K091274 · Barco N.V. · Jul 2009
VITREA ENDOVASCULAR STENT PLANNING SOFTWARE
K091498 · Vital Images, Inc. · Jun 2009
R2 DIGITALNOW HD(DIGITALNOW HD)
K091368 · Hologic, Inc. · Jun 2009
SYNGO TRUED
K091373 · Siemens Medical Solutions USA, Inc. · May 2009